Document is current
Any future updates will be listed below
-
Authors
Ianhez, Mayra https://orcid.org/0000-0003-3604-3128
Luz, Allana Rodrigues César Araújo
Palermo, Eliandre Costa
Miot, Hélio Amante
- License Information
-
More Information
Article History
Received: 11 June 2023
Accepted: 13 August 2023
First Online: 13 September 2023
Declarations
:
: The authors declare that they have no conflicts of interest to disclose regarding this manuscript. Dr Mayra Ianhez has worked as a speaker for Abbvie, Sanofi-Genzyme, Leopharma, Pfizer, Janssen, Biolab, Galderma, Theraskin, Novartis, FQM and Vichy. Dr Allana Luz has no conflict of interest to declare. Dr Eliandre Palermo has worked as a speaker for Galderma and participated in advisory board for Medbeauty. Dr Hélio Miot has developed research and worked as speaker for Merz, Pfizer, Vichy, La Roche Posay, Eucerin, Abbvie, and Pierre-Fabre.
: This research has been approved by the Ethics Committee of Hospital of Tropical Diseases, Goiânia-Brazil, under the number CAAE 66814122.5.0000.0034, under the number 5.879.639.
: Informed consent was given electronically by all physicians who participated in this research interview.
